The head of a vaccine manufacturer in India says that the limitation on quantity of vaccine available is the challenge of scaling up production.

Maybe that is so, but nonetheless it seems like we are producing vaccine too slowly. To stretch it out over 18 months is more efficient, for sure, but producing twice as fast could save millions from dying from Covid-19 during the extra 9 months.